Medsearch

an established medical recruitment agency,focusing on integrity & client service,our team is equipped to assist in all aspects of recruitment&career development

[Medsearch @medsearch_sa]

Amgen reacquires all product rights to Prolia® (denosumab), XGEVA® (denosumab) and Vectibix® (panitumumab) from GSK…https://t.co/4vhekjuQKK

[Medsearch @medsearch_sa]

AstraZeneca to strengthen therapy area franchise through acquisition of Takeda's respiratory business https://t.co/YbKF4sGUUT

[Medsearch @medsearch_sa]

Novo Nordisk and IBM partner to build diabetes care solutions on the Watson Health Cloud https://t.co/rcJffkDJXQ

[Medsearch @medsearch_sa]

300 million child-friendly antimalarial treatments supplied without profit by Novartis https://t.co/G3ETn8GAzt

[Medsearch @medsearch_sa]

Daratumumab combined with standard treatment for multiple myeloma produced deep and durable responses in relapsed or…https://t.co/4TFumdnT8U

[Medsearch @medsearch_sa]

Scientists find unique anti-diabetes compound using powerful new drug-discovery method https://t.co/jNZh50KTeW

[Medsearch @medsearch_sa]

Targeting protein homeostasis holds potential to treat solid tumors and blood cancers https://t.co/PrZosuGDsq

[Medsearch @medsearch_sa]

Synapse discovery could lead to new treatments for Alzheimer's disease https://t.co/ACv6PPNLpl

[Medsearch @medsearch_sa]

Aspirin targets key protein in neurodegenerative diseases https://t.co/Mvm2418qVr

[Medsearch @medsearch_sa]

Synapse discovery could lead to new treatments for Alzheimer's disease https://t.co/SaxYcN1X5X

[Medsearch @medsearch_sa]

Bristol-Myers Squibb Foundation marks World AIDS Day with grants totaling more than $3.5M https://t.co/Xn71EdYRdE

[Medsearch @medsearch_sa]

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate) https://t.co/kUzCf2Rije

[Medsearch @medsearch_sa]

New research suggests a novel route in the fight against cancer https://t.co/NNwLAA2Dbu

[Medsearch @medsearch_sa]

AstraZeneca enters into agreement with Perrigo for rights to Entocort® in the US https://t.co/Ud2525z8MW

[Medsearch @medsearch_sa]

Merck and Pfizer receive FDA Breakthrough Therapy designation for avelumab in metastatic Merkel cell carcinoma https://t.co/pncqnINREb

[Medsearch @medsearch_sa]

Big pharma inconsistent with disclosure of information on clinical trials https://t.co/Ny9r5tbfuD

[Medsearch @medsearch_sa]

Scientists trace activity of cancer-fighting tomato component https://t.co/je328WJn60

[Medsearch @medsearch_sa]

Boehringer Ingelheim will invest 11 billion euros in Research and Development in the next five years https://t.co/2uZsTwN1zx

[Medsearch @medsearch_sa]

Diabetes drug reduces risk of heart failure and may prevent it https://t.co/vumtULtKvD

[Medsearch @medsearch_sa]

Boehringer Ingelheim partners with leading scientific institutions in inflammatory bowel disease research https://t.co/TUkHTImmTB